Proton pump inhibitor associated hypomagnasaemia ‐ a cause for concern?. (25th January 2016)
- Record Type:
- Journal Article
- Title:
- Proton pump inhibitor associated hypomagnasaemia ‐ a cause for concern?. (25th January 2016)
- Main Title:
- Proton pump inhibitor associated hypomagnasaemia ‐ a cause for concern?
- Authors:
- Begley, Joe
Smith, Trevor
Barnett, Kirsty
Strike, Paul
Azim, Adnan
Spake, Claire
Richardson, Tristan - Abstract:
- Abstract : Aims: In recent years, there have been a number of case reports of severe hypomagnesaemia associated with proton pump inhibitor (PPI) use, such that both the FDA and MHRA have issued drug safety warnings. They have recommended periodic serum magnesium testing in patients prescribed PPIs but provide no guidance on timing of these measurements. Methods: To our knowledge, we are the first to perform a prospective study to explore specifically proton pump inhibitor associated hypomagnesaemia (PPIAH). We followed 56 patients new to PPIs prospectively as well as a further 100 patients on long term PPIs cross‐sectionally to identify what factors may be influencing the development of significant hypomagnesaemia. Results: For the prospective arm of the study, we measured serum magnesium levels prior to starting a PPI and again at regular intervals for the next 8 months. For the cross‐sectional arm of the study we measured serum magnesium levels on patients on PPI therapy ranging from less than 1 year to over 5 years. Conclusion: We found that, although there was a significant downward trend in serum magnesium levels in patients new to PPI therapy with time, clinically relevant hypomagnesaemia was not readily identifiable on regular blood testing. We did however identify patients on concurrent diuretic therapy as being at higher risk and so would recommend regular serum magnesium testing alongside their regular renal function monitoring on a more frequent basis such asAbstract : Aims: In recent years, there have been a number of case reports of severe hypomagnesaemia associated with proton pump inhibitor (PPI) use, such that both the FDA and MHRA have issued drug safety warnings. They have recommended periodic serum magnesium testing in patients prescribed PPIs but provide no guidance on timing of these measurements. Methods: To our knowledge, we are the first to perform a prospective study to explore specifically proton pump inhibitor associated hypomagnesaemia (PPIAH). We followed 56 patients new to PPIs prospectively as well as a further 100 patients on long term PPIs cross‐sectionally to identify what factors may be influencing the development of significant hypomagnesaemia. Results: For the prospective arm of the study, we measured serum magnesium levels prior to starting a PPI and again at regular intervals for the next 8 months. For the cross‐sectional arm of the study we measured serum magnesium levels on patients on PPI therapy ranging from less than 1 year to over 5 years. Conclusion: We found that, although there was a significant downward trend in serum magnesium levels in patients new to PPI therapy with time, clinically relevant hypomagnesaemia was not readily identifiable on regular blood testing. We did however identify patients on concurrent diuretic therapy as being at higher risk and so would recommend regular serum magnesium testing alongside their regular renal function monitoring on a more frequent basis such as annually. … (more)
- Is Part Of:
- British journal of clinical pharmacology. Volume 81:Number 4(2016:Apr.)
- Journal:
- British journal of clinical pharmacology
- Issue:
- Volume 81:Number 4(2016:Apr.)
- Issue Display:
- Volume 81, Issue 4 (2016)
- Year:
- 2016
- Volume:
- 81
- Issue:
- 4
- Issue Sort Value:
- 2016-0081-0004-0000
- Page Start:
- 753
- Page End:
- 768
- Publication Date:
- 2016-01-25
- Subjects:
- hypomagnesaemia -- magnesium -- proton pump inhibitors
Pharmacology -- Periodicals
Drugs -- Periodicals
615.1 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2125 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/bcp.12846 ↗
- Languages:
- English
- ISSNs:
- 0306-5251
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2307.180000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2395.xml